|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kang Y, Li S, Ge Q, Liu X, Yang Z, Xue Y
and Wang F: Extent of serosal changes predicts peritoneal
recurrence and poor prognosis after curative surgery for gastric
cancer. Medicine (Baltimore). 94:e17502015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wagner AD, Grothe W, Haerting J, Kleber G,
Grothey A and Fleig WE: Chemotherapy in advanced gastric cancer: A
systematic review and meta-analysis based on aggregate data. J Clin
Oncol. 24:2903–2909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tacar O, Sriamornsak P and Dass CR:
Doxorubicin: An update on anticancer molecular action, toxicity and
novel drug delivery systems. J Pharm Pharmacol. 65:157–170. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu J, Liu D, Niu H, Zhu G, Xu Y, Ye D, Li
J and Zhang Q: Resveratrol reverses Doxorubicin resistance by
inhibiting epithelial-mesenchymal transition (EMT) through
modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin
Cancer Res. 36:192017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Q, Wang Y, Peng B, Liang L and Li J:
The roles of Notch1 expression in the migration of intrahepatic
cholangiocarcinoma. BMC Cancer. 13:2442013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ke Z, Mao X, Li S, Wang R, Wang L and Zhao
G: Dynamic expression characteristics of Notch signal in bone
marrow-derived mesenchymal stem cells during the process of
differentiation into hepatocytes. Tissue Cell. 45:95–100. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiu H, Tang X, Ma J, Shaverdashvili K,
Zhang K and Bedogni B: Notch1 autoactivation via transcriptional
regulation of furin, which sustains Notch1 signaling by processing
Notch1-activating proteases ADAM10 and membrane type 1 matrix
metalloproteinase. Mol Cell Biol. 35:3622–32. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Soylu H, Acar N, Ozbey O, Unal B, Koksal
IT, Bassorgun I, Ciftcioglu A and Ustunel I: Characterization of
Notch signalling pathway members in normal prostate, prostatic
intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
Pathol Oncol Res. 22:87–94. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Colomer-Lahiguera S and Strehl S:
Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell
acute lymphoblastic leukemia. Leuk Lymphoma. 57:1219–1222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rodriguez JM, Miranda D, Bunout D, Ronco
AM, de la Maza MP and Hirsch S: Folates induce colorectal carcinoma
HT29 cell line proliferation through Notch1 signaling. Nutr Cancer.
67:706–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hassan WA, Yoshida R, Kudoh S, Hasegawa K,
Niimori-Kita K and Ito T: Notch1 controls cell invasion and
metastasis in small cell lung carcinoma cell lines. Lung Cancer.
86:304–310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yeh TS, Wu CW, Hsu KW, Liao WJ, Yang MC,
Li AF, Wang AM, Kuo ML and Chi CW: The activated Notch1 signal
pathway is associated with gastric cancer progression through
cyclooxygenase-2. Cancer Res. 69:5039–5048. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harada K, Sato Y, Ikeda H, Hsu M, Igarashi
S and Nakanuma Y: Notch1-Hes1 signalling axis in the tumourigenesis
of biliary neuroendocrine tumours. J Clin Pathol. 66:386–391. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pedrosa AR, Graça JL, Carvalho S,
Peleteiro MC, Duarte A and Trindade A: Notch signaling dynamics in
the adult healthy prostate and in prostatic tumor development.
Prostate. 76:80–96. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hassan WA, Yoshida R, Kudoh S, Kameyama H,
Hasegawa K, Niimori-Kita K and Ito T: Notch1 controls cell
chemoresistance in small cell lung carcinoma cells. Thorac Cancer.
7:123–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lian W, Zhang L, Yang L and Chen W: AP-2α
reverses vincristine-induced multidrug resistance of SGC7901
gastric cancer cells by inhibiting the Notch pathway. Apoptosis.
22:933–941. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou W, Fu XQ, Zhang LL, Zhang J, Huang X,
Lu XH, Shen L, Liu BN, Liu J, Luo HS, et al: The
AKT1/NF-kappaB/Notch1/PTEN axis has an important role in
chemoresistance of gastric cancer cells. Cell Death Dis.
4:e8472013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang XS, Hu YH, Gao HY, Lan XW and Xue
YW: Downregulation of Notch1 inhibits the invasion and metastasis
of human gastric cancer cells SGC7901 and MKN74 in vitro through
PTEN activation and dephosphorylation of Akt and FAK. Mol Med Rep.
16:2318–2324. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
World Medical Association, . World Medical
Association Declaration of Helsinki: ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang M, Chen DQ, Chen L, Liu D, Zhao H,
Zhang ZH, Vaziri ND, Guo Y, Zhao YY and Cao G: Novel RAS inhibitors
poricoic acid ZG and poricoic acid ZH attenuate renal fibrosis via
Wnt/β-catenin pathway and targeted phosphorylation smad3 signaling.
J Agric Food Chem. 66:1828–1842. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
National Research Council, . Committee for
the Update of the Guide for the Care and Use of Laboratory,
Institute for Laboratory Animal Research and Division on Earth and
Life Studies: Guide for the Care and Use of Laboratory Animals. 8th
edition. The National Academies Press; Washington, DC: 2011
|
|
23
|
Fender AW, Nutter JM, Fitzgerald TL,
Bertrand FE and Sigounas G: Notch-1 promotes stemness and
epithelial to mesenchymal transition in colorectal cancer. J Cell
Biochem. 116:2517–2527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hsu KW, Hsieh RH, Huang KH, Li Fen-Yau A,
Chi CW, Wang TY, Tseng MJ, Wu KJ and Yeh TS: Activation of the
Notch1/STAT3/Twist signaling axis promotes gastric cancer
progression. Carcinogenesis. 33:1459–1467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang H, Wang X, Xu J and Sun Y: Notch1
activation is a poor prognostic factor in patients with gastric
cancer. Br J Cancer. 110:2283–2290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Villasmil ML, Francisco J, Gallo-Ebert C,
Donigan M, Liu HY, Brower M and Nickels JT Jr: Ceramide signals for
initiation of yeast mating-specific cell cycle arrest. Cell Cycle.
15:441–454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seo JH, Jeong ES and Choi YK: Therapeutic
effects of lentivirus-mediated shRNA targeting of cyclin D1 in
human gastric cancer. BMC Cancer. 14:1752014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vadde R, Radhakrishnan S, Reddivari L and
Vanamala JK: Triphala extract suppresses proliferation and induces
apoptosis in human colon cancer stem cells via Suppressing
c-Myc/Cyclin D1 and elevation of Bax/Bcl-2 ratio. Biomed Res Int.
2015:6492632015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu E, Liang T, Wang X, Ban S, Han L and
Li Q: Apoptosis induced by farrerol in human gastric cancer
SGC-7901 cells through the mitochondrial-mediated pathway. Eur J
Cancer Prev. 24:365–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choi JH, Lim HY, Joo HJ, Kim HS, Yi JW,
Kim HC, Cho YK, Kim MW and Lee KB: Expression of multidrug
resistance-associated protein1, P-glycoprotein, and thymidylate
synthase in gastric cancer patients treated with 5-fluorouracil and
doxorubicin-based adjuvant chemotherapy after curative resection.
Br J Cancer. 86:1578–1585. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu HG, Ai YW, Yu LL, Zhou XD, Liu J, Li
JH, Xu XM, Liu S, Chen J, Liu F, et al: Phosphoinositide
3-kinase/Akt pathway plays an important role in chemoresistance of
gastric cancer cells against etoposide and doxorubicin induced cell
death. Int J Cancer. 122:433–443. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cui J, Jiang W, Wang S, Wang L and Xie K:
Role of Wnt/β-catenin signaling in drug resistance of pancreatic
cancer. Curr Pharm Des. 18:2464–2471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang KD and Ling MT: Targeting
drug-resistant prostate cancer with dual PI3K/mTOR inhibition. Curr
Med Chem. 21:3048–3056. 2013. View Article : Google Scholar
|
|
34
|
Zhao Y and Yang X: The Hippo pathway in
chemotherapeutic drug resistance. Int J Cancer. 137:2767–2773.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Broxterman HJ, Gotink KJ and Verheul HM:
Understanding the causes of multidrug resistance in cancer: A
comparison of doxorubicin and sunitinib. Drug Resist Updat.
12:114–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kang X, Li M, Zhu H, Lu X, Miao J, Du S,
Xia X and Guan W: DUSP4 promotes doxorubicin resistance in gastric
cancer through epithelial-mesenchymal transition. Oncotarget.
8:94028–94039. 2017.PubMed/NCBI
|
|
37
|
Wagner W, Kania KD, Blauz A and Ciszewski
WM: The lactate receptor (HCAR1/GPR81) contributes to doxorubicin
chemoresistance via ABCB1 transporter up-regulation in human
cervical cancer HeLa cells. J Physiol Pharmacol. 68:555–564.
2017.PubMed/NCBI
|
|
38
|
Rizzo S, Cangemi A, Galvano A, Fanale D,
Buscemi S, Ciaccio M, Russo A, Castorina S and Bazan V: Analysis of
miRNA expression profile induced by short term starvation in breast
cancer cells treated with doxorubicin. Oncotarget. 8:71924–71932.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kotiyal S and Bhattacharya S: Breast
cancer stem cells, EMT and therapeutic targets. Biochem Biophys Res
Commun. 453:112–116. 2014. View Article : Google Scholar : PubMed/NCBI
|
